LDLR and atherosclerosis: Specifically, LDL-R−/− mice fed a high-cholesterol Western diet and treated with intraperitoneal administration of FTY720 showed a dose-dependent reduction in atherosclerosis plaque formation and a reduction in the release of pro-inflammatory cytokines such as TNF-1α and IL-6 [222].